Development of immunotherapy and nanoparticles-based strategies for the treatment of Parkinson's disease

R Duwa, JH Jeong, S Yook - Journal of Pharmaceutical Investigation, 2021 - Springer
Background Parkinson's disease (PD) is the most common progressive neurodegenerative
disorder and is characterized by the degeneration of dopamine (DA) neurons in the …
被引用次数：21 相关文章
[PDF] researchgate.net

[PDF][PDF] Development of immunotherapy and nanoparticles‑based strategies for the treatment of Parkinson's disease

R Duwa, JH Jeong, S Yook - 2021 - researchgate.net
Background Parkinson's disease (PD) is the most common progressive neurodegenerative
disorder and is characterized by the degeneration of dopamine (DA) neurons in the …

Development of immunotherapy and nanoparticles-based strategies for the treatment of Parkinson's disease

D Ramesh, Y Simmyung - Journal of Pharmaceutical Investigation, 2021 - dbpia.co.kr
Background Parkinson's disease (PD) is the most common progressive neurodegenerative
disorder and is characterized by the degeneration of dopamine (DA) neurons in the …

Development of immunotherapy and nanoparticles-based strategies for the treatment of Parkinson's disease

R Duwa, JH Jeong, SM Yook - Journal of Pharmaceutical …, 2021 - oldkmbase.medric.or.kr
Background: Parkinson's disease (PD) is the most common progressive neurodegenerative
disorder and is characterized by the degeneration of dopamine (DA) neurons in the …

Development of immunotherapy and nanoparticles-based strategies for the treatment of Parkinson's disease

R Duwa, JH Jeong, SM Yook - Journal of Pharmaceutical …, 2021 - oldkmbase.medric.or.kr
Background: Parkinson's disease (PD) is the most common progressive neurodegenerative
disorder and is characterized by the degeneration of dopamine (DA) neurons in the …